AKBA vs AMLX: Side-by-Side Comparison
Compare Akebia Therapeutics Inc (AKBA) and Amylyx Pharmaceuticals Inc (AMLX) side by side: market cap USD 332.64M vs USD 2.03B. Financials, growth and model signals on Bullrun.
| Metric | AKBA | AMLX |
|---|---|---|
| Company | Akebia Therapeutics Inc | Amylyx Pharmaceuticals Inc |
| Country / Exchange | United States · NASDAQ | United States · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers-Specialty & Generic | Drug Manufacturers-Specialty & Generic |
| Market cap | USD 332.64M | USD 2.03B |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | USD 236.20M | USD 0 |
| Revenue growth YoY | +47.5% | -100.0% |
| Net income | USD -5.30M | USD -144.74M |
| Gross margin | 83.3% | — |
| Diluted EPS | -0.02 | -1.53 |